Autolus Therapeutics (AUTL) Intangibles (2018 - 2026)

Autolus Therapeutics (AUTL) has 7 years of Intangibles data on file, last reported at $19.8 million in Q4 2025.

• Quarterly Intangibles rose 60.1% year-over-year to $19.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $19.8 million (up 60.1% YoY) and the FY2025 annual result came in at $19.8 million, up 60.1% from the prior year.
• Intangibles retreated to $19.8 million in Q4 2025, from $20.3 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $20.3 million in Q3 2025 to a low of $8000.0 in Q3 2022.
• A 4-year average of $6.5 million and a median of $123500.0 in 2021 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2022 — Intangibles sank 90.8% — and 2025, when it surged 60.1%.
• Tracing AUTL's Intangibles over 4 years: stood at $65000.0 in 2021, then tumbled by 87.69% to $8000.0 in 2022, then soared by 154562.5% to $12.4 million in 2024, then surged by 60.1% to $19.8 million in 2025.
• The last three Intangibles figures came in at $19.8 million (Q4 2025), $20.3 million (Q3 2025), and $12.9 million (Q2 2025), per Business Quant data.